Literature DB >> 18590533

Changes in the predominant human Lactobacillus flora during in vitro fertilisation.

Tell Jakobsson1, Urban Forsum.   

Abstract

BACKGROUND: Signature matching of nucleotide sequences in the V1 and V3 regions 16S rRNA genes using pyrosequencing technology is a powerful tool for typing vaginal Lactobacilli to the species level and has been used for investigating the vaginal microbial niche.
METHODS: This study has characterized the normal cultivable vaginal Lactobacillus flora at varying estradiol levels in plasma; the study comprised 17 patients undergoing ovarian stimulation for In Vitro Fertilization (IVF) treatment. The vaginal status of each participant was initially assessed as normal according to Amsel and Nugent criteria.
RESULTS: L. crispatus, L. gasseri and/or L. jensenii were present in 10 of the patients throughout the study period, and little variation among these three species was encountered in individual patients. The flora of three women was dominated by L. delbrüeckii, L. rhamnosus or L. vaginalis. One woman exhibited a dominance of L. iners. The flora of the remaining three women were initially dominated by L. rhamnosus or L. reuteri, but as their estrogen levels rose, their flora composition altered, to become dominated by one of the three species most common in a normal, healthy vagina.
CONCLUSION: Signature matching of nucleotide sequences in the V1 and V3 regions of 16S rRNA genes is a discriminative tool for the study of vaginal Lactobacilli and can be used to track the Lactobacillus flora under a variety of physiological conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18590533      PMCID: PMC2474650          DOI: 10.1186/1476-0711-7-14

Source DB:  PubMed          Journal:  Ann Clin Microbiol Antimicrob        ISSN: 1476-0711            Impact factor:   3.944


Background

For more than a century, science has known that the Döderlein bacilli dominate the observable microflora of the normal healthy vagina of women of reproductive age; microscopic studies show Gram-positive rods to be predominant. An altered cultivable flora arises when the number of lactobacilli in the vaginal fluid drastically decreases, and opportunistic bacteria, normally present in minute proportions, overgrow the vaginal epithelium. This leads to a rising pH (>4,7) which is conducive to the growth of anaerobes [1]. Maintenance of the normal vaginal flora is supposedly essential because it not only occupies the epithelial surface, but also constitutes a milieu hostile to attacks of pathogens [2]. A prevailing assumption is that the dominating normal vaginal flora comprises the genus Lactobacillus more specifically now known as the L. acidophilus complex. This assumption is based on earlier literature describing studies using phenotypic methods for typing bacteria and a line of reasoning about the bacterial ecology of normal niches in humans [1]. To acquire further insight into microbial variation of normally occurring bacterial population in defined biological niches, it is important to look closely at the physiology of the particular niche [3]. Conditions making up the niche must be defined. The clinical criteria of Amsel [4] and the scoring system of Nugent [5] provide means for categorizing vaginal flora as normal or otherwise, though mainly in relation to the clinical entity bacterial vaginosis (BV) [6]. Certain physiological conditions are generally assumed necessary if lactobacilli are to thrive in the healthy vagina of a woman of childbearing age. One such factor is the glycogen contents of the vaginal epithelium that co-variates with estrogen levels. During stimulation for in vitro fertilization (IVF), estrogen levels can range from extremely low at the start of treatment to high during pregnancy. This provides an opportunity, to study vaginal flora variation in circumstances that mirror the normal hormonal variation occurring a woman's lifetime. We have previously published studies on healthy women whose vaginal flora status is deemed normal according to Amsel and Nugent [6,7]. Using traditional phenotypic methods, as well as genotypic methods, we confirmed and extended earlier studies implicating L. crispatus, L. gasseri, L. jensenii [1,8], and adding L. iners [9] to the list of vaginal Lactobacilli which normally dominate. The importance of a true random sample to study the dominant vaginal flora in contrast to bacterial strains from culture collections was also made clear [7]. In a second study [6], we used PCR with pyrosequencing followed by signature matching with published type strain sequences as the chosen method to identify those Gram-positive rods constituting the dominant vaginal flora. Both studies were performed on a defined population of fertile, healthy women scheduled for a regular PAP smear. In the first study, three colonies were selected from each sample, in the second, up to ten colonies were studied from each cultured sample. Both studies showed dominance by L. crispatus, L. jensenii and/or L. gasseri, and in some cases, the newly described, L. iners. These findings agree with reports from other parts of the world, even those studies having poorly defined inclusion criteria and those including strains from culture collections [1]. Our research also shows that three randomly collected colonies will represent the dominating flora. Using a similar approach and definitions according to Amsel and Nugent criteria, this study aims at further characterizing the normal cultivable vaginal flora present at differing estradiol levels in plasma during ovarian stimulation for IVF treatment.

Material & Methods

The population was recruited from patients with uneventful medical and STD history attending the Reproductive Medicine Centre, Dept of Obstetrics and Gynecology, University Hospital, Linköping, Sweden during January to March 1999 for the final examination prior to IVF stimulation. These women gave their informed consent to participate in the study. Of 34 women who originally agreed to participate, 13 were excluded. In total, the vaginal fluids of 17 patients were cultured on 62 occasions, three to five times per patient. Of the excluded patients, five patients did not fulfill the Amsel and/or Nugent criteria for normal vaginal status, and eight dropped out after one or two visits. Among the patients who returned only once, four exhibited Gram-positive rods growing on horse blood agar, but not on Rogosa agar. Since these strains might nonetheless belong to the dominating normal flora, we included these samples in our analyses. The standard IVF protocol (Fig. 1), in accordance with the national Swedish guidelines in effect at the time of the study, started by down regulation with a Gonadotropin Releasing Hormone (GnRH)-analog, nasal administration four times daily, from the 21st day after the start of the menstrual period. Two weeks later, following withdrawal bleeding and a uterine ultrasound that ascertained a minimal endometrium, Follicle Stimulation Hormone (FSH)-stimulation began. After six to eight daily injections, the patient returned to the clinic for an ultrasound check of follicular growth, and thereafter at two to four day intervals until ovum pick-up, and two days after pick-up, for embryo transfer. Six of the patients established a pregnancy and returned for an ultrasound check about six weeks after embryo transfer. At each visit (except at embryo transfer), the level of estradiol in plasma was measured.
Figure 1

Protocol of ovulation stimulation in relation to collection of vaginal samples from women undergoing In Vitro Fertilization (IVF) treatment. GnRH = Gonadotropin Releasing Hormone, FSH = Follicle Stimulating Hormone, OPU = Ovum Pick Up, ET = Embryo Transfer.

Protocol of ovulation stimulation in relation to collection of vaginal samples from women undergoing In Vitro Fertilization (IVF) treatment. GnRH = Gonadotropin Releasing Hormone, FSH = Follicle Stimulating Hormone, OPU = Ovum Pick Up, ET = Embryo Transfer. In accordance with the protocol, all patients prior to the IVF treatment, ingested prophylactic antibiotics; doxycyclin 200 mg day one, and 100 mg daily for another 8 days, metronidazole 3 times daily for a week. 16 of the patients started IVF treatment 1 to 2 months later. The male partners of the patients were concurrently given the same antibiotic prophylaxis. For six patients, treatment start was further delayed as much as seven months after the antibiotic treatment. The study was approved prior to its start by the ethics review board for Southeast Sweden.

Culture

At each visit, vaginal fluid was sampled from the upper third of the vagina by rolling a cotton swab against the lateral wall using a non-lubricated speculum. The swabs were placed in modified Stuart's medium (Copan transport medium, Venturi Transystem, Brescia, Italy) and transported to the laboratory for culture within 3 hours. With another swab, fluid was sampled from the same location and smeared onto a glass slide, which was air-dried, heat-fixed and Gram-stained. The culture swabs were vortexed briefly in phosphate-buffered saline (PBS), pH 7.2 and diluted in PBS to 1/100, 1/1000 and 1/10 000. One ml of each dilution was plated on horse blood agar and on Rogosa agar (preparation in-house based on Difco media). The plates were incubated for two to four days under microaerophilic conditions (10% CO2 and 5% O2) at 37°C.

Selection of strains

When growth on Rogosa agar was successful, no colonies were collected from the horse blood agar Petri dishes. If colonies grew only on horse blood agar, they were collected there. Whenever possible, the isolates were picked from the plate with a dilution of 1/10 000 and at a growth of 25 to 100 colonies per dish. To obtain true randomly selected isolates, the dish was reversed and three spots marked with a felt tip pen. When the plate was turned right side up, the spots were clearly visible through the agar. The colony nearest each of the three spots was selected for re-culture under the conditions described above. The colonies were checked for possible impurities with a Gram-stained smear and colony morphology. The bacterial isolates thus obtained were frozen at -70°C in a storage medium based on Nutrient Broth no.2 (Lab M Bury, UK) and 15% glycerol.

PCR and pyrosequencing

Broad-range PCR followed by pyrosequencing was performed as previously described [6,10]. Primer pairs used for PCR were: 1. bio-pBR 5'.se (position 6–27, E. coli numbering [11]): 5'-biotin-GAAGAGTTTGATCATGGCTCAG-3'; pBR-V1.as (position 120–101): 5'-TTACTCAAAAGTCCGCCACT-3' 2. bio-pJBS-V3.se (position 966–985): 5'-biotin-GCAACGCGAAGAACCTTACC-3'; B-V3.as (position 1065–1046): 5'-AGGTGCTGCATGGCTGTCGT-3' 3. bio-B-V3.as and pJBS-V3.se Sequencing primers used: pBR-V1.as, pJBS-V3.se and B-V3.as. Primers were obtained from Scandinavian Gene Synthesis, Köping, Sweden. DNA was prepared with PrepMan™ (Applied Biosystems) lysis reagent. A colony from each isolate was suspended in 50 μl of PrepMan reagent, vortexed, heated in a water bath at 99°C for ten min and centrifuged at 16000 × g for three min. The supernatant was used as DNA template. The PCR amplification was initially performed in 0.5 ml thin-walled tubes with Ready-to-go beads™ (Amersham Pharmacia, Uppsala, Sweden) on a PTC-100 model thermocycler (MJ Research Inc., Falkenberg, Sweden). For the major part of the study, PCR was performed in 96-well plates with 5 pmol of each primer, 12.5 μl HotStar Taq (Qiagen, Hilden, Germany), 10.5 μl H2O and 2 μl of the prepared DNA template. The PCR was run on a Mastercycler gradient thermocycler (Eppendorf, Hamburg, Germany) with denaturation at 95°C for 15 min, followed by 28–32 cycles of denaturation at 94°C for 40 s, annealing at 55°C for 40 s, extension at 72°C for 1 min; with a final extension step 72°C for 10 min. Agarose gel electrophoresis was performed only on a few samples at the beginning of the study to assure that a PCR product of expected length was obtained. Pyrosequencing was performed as earlier described [10].

Bioinformatics

One nucleotide (nt) signature from each sampling was initially screened by comparing with sequences in GenBank using the BLASTn algorithm [12]. Eleven separate categories of signatures were identified, each matching a sequence of a strain deposit in the GenBank library and published in PubMed; our preference was for type strains deposited in ATCC or in certain cases, type strains from other sources. Each category of sequences was compared with previously published reference sequences on vaginal samples (Table 1).
Table 1

List of reference strains used to group found signatures of 16s rDNA.

SpeciesStrainGenBank noReferenceReference 2
L. acidophilusaATCC4356TAY773947Kao 2007Falsen 1999
L. caseiATCC334TNC008530Makarova 2006Falsen 1999
L. crispatusKC12aAF243152Pavlova 2002
L. delbrueckiiATCC9649TAY050172Germond 03Falsen1999
L. fermentumKC5b(ATCC14931)AF243166Pavlova 202Falsen 1999
L. gallinarumATCC3319TAJ242968Ventura 2000Falsen1999
L. gasseriKC5a(ATCC33323)AF243165Pavlova 2002
L. inersCCUG28746TY16329Falsen 1999Falsen 1999
L. jenseniiATCC25258TAF243176Pavlova 2002Falsen 1999
L. jenseniiKC36bAF243159Pavlova 2002
L. jenseniiKC23AF243155Pavlova 2002
L. johnsoniiATCC33200TAJ002515Fujisawa 1992Falsen 1999
L. mucosaeBLB1cAF243145Pavlova 2002
L. paracaseiKLB58AF243168Pavlova 2002
L. reuteriLU3(DSM20016)AY735406UnpublFalsen 1999
L. rhamnosusF11(ATCC7469)AF243146Pavlova 2002
L. vaginalisKC19AF243154Pavlova 2002
L. crispatusbATCC33820TAF257097Pavlova 2002Falsen 1999
L. kimchiiAP1077TAF 183558Yoon 2000
L. paraalimentariusTB1TAB018528Cai 1999
L. paracaseiDSM5622TD79212Mori 1997Falsen 1999
L. vaginalisATCC49540TAF243177Pavlova 2002Falsen 1999
L. acidophilusNCFMNC006814Altermann 2005
L. brevisATCC367TNC008497Makarova 2006
L. delb. sp. bulgaricusATCC11842TNC008054Van de Guchte 2006
L. gasseriATCC33323TNC008530Makarova 2006
L. johnsoniiNCC533NC005362Pridemore 2004
L. plantarumWCFS1NC004567Kleerebezem 2004
L. reuteriF275NC009513unpublished
L. sak. sakei23KNC007576Chaillou 2005
L. sal. salivariusUCC118NC007929Claesson 2006

a/Selected reference strains (vaginal samples, in bold, chosen if existing)

b/Additional culture collection strains (of other than vaginal or no information as to origin) with sequences similar to the ones above and whole genome sequenced strains of lactobacilli.

List of reference strains used to group found signatures of 16s rDNA. a/Selected reference strains (vaginal samples, in bold, chosen if existing) b/Additional culture collection strains (of other than vaginal or no information as to origin) with sequences similar to the ones above and whole genome sequenced strains of lactobacilli. Other published sequences from Lactobacillus outside the vaginal niche used for comparison of sequences are listed separately, among them, all whole genome sequences of Lactobacillus species published to date(Dec. 2007). Reference 16S rRNA gene sequences of vaginal origin were aligned and arranged in BioEdit [13] with Clustal W and with the Mega3 [14] software. The signatures of the V1 and V3 regions were checked for their ability to discriminate to the species level. The minimal length of discrimination between sequences of reference strains is for the V1 region described in Fig. 2. Positions refers to E. coli numbering[11]. The sequences of the V3 region, as shown in Fig. 3, are sufficiently varied to distinguish among all identified species in the study in both sense and antisense directions, however some of the other strains presented in Fig. 2 demonstrate identical sequences in the V3 region. This is e.g. the case comparing the signatures of L. gasseri and L. johnsonii, which indicates that the signature of V1 is necessary to group the strains.
Figure 2

Nucleotide sequence of the V1 region base 100–75 of the 16S rDNA in E. coli numbering for reference strains[11].

Figure 3

Nucleotide sequences of the entire V3 region of 16S rDNA for the nine E. coli numbering for reference strains[11].

Nucleotide sequence of the V1 region base 100–75 of the 16S rDNA in E. coli numbering for reference strains[11]. Nucleotide sequences of the entire V3 region of 16S rDNA for the nine E. coli numbering for reference strains[11]. For the V1 region, the signature of the first seven nts proved sufficient to discriminate all strains in the study as well as the sequences of reference strains of vaginal origin. There was one exception, namely L. casei and L. (casei subspecies) paracasei that also share identical sequences for both V1 and V3 region. For the sense direction of the V3 region, a signature length of 26 nts was required to group the isolates. For the antisense direction of the V3 region, 11 nts was sufficient, except for separating L. rhamnosus and L. vaginalis where 28 nts were needed.

Results and Discussion

In order to find signatures for the lactobacilli included in the study, 184 out of 186 lactobacillus isolates were subjected to PCR and pyrosequencing of the 16S rRNA gene regions V1 and V3. Three sequences were obtained for each strain subjected to PCR and pyrosequencing, one for the V1 region and two complementary sequences for the V3 region. All were categorized separately and matched with the sequence of the reference strain of each species (for L. jensenii also two subtypes). Of a possible 552 sequences, 519 were suitable for sequence analysis. Tentative assignment of all vaginal strains to individual "species-like" categories was now possible by estimating the required length of signatures. I. For the V1 region, only the first eleven nts were required to make a unique match of each group with one of the chosen published sequences of vaginal strains. II. Whenever more than 30 matching nts in each direction of the two V3-sequences were obtained, that sequence was assumed to be the true sequence of the complete V3 region as well as if there was a complete match of all the 60 nts of the region. This was the case for most strains. III. Similarity was also assumed when there was a match of at least 30 nts in either sense or antisense direction of the V3 region. A match fulfilling the criteria of highest similarity (I and II) was obtained in 109 isolates. When I or II was fulfilled, it was assumed to be the second best identity and this was the case in 41 isolates. Third grade of identification (I or III) was found in 25 isolates. The 8 remaining isolates did not yield unique identity per se. These could be categorized by other means. Three of these strains originated from patient 17 who demonstrated a predominant flora of lactobacilli growing only on horse blood agar. Though not fulfilling any of the criteria stated above, for the purpose of the study at hand, these strains are assumed to be L. iners-like. Three strains originated from one sample derived from patient 7. All three colonies yielded sequences matching L. gasseri or L. vaginalis, but varying within one and the same template from a specific colony. This sample was assumed to be impure and to consist of a mix of two separate strains. Still two samples from two different patients demonstrated the same type of discrepancy. All these strains were assigned to the most probable species when we defined the results from other colonies originating from the same patient. The signature matching L. jensenii-like strains could be further subtyped into three different signature groups, each matching a strain previously published in PubMed [8]. As regards the ATCC strains listed, they differed in the V1 region only, with a variation of nts in the same two positions of the subtypes; one of which had a variation in a third position (Fig 2). Each patient exhibited only one of the subtypes in all obtained signatures. For signature matching of L. gasseri, a homology was found in the V1 region sequence of one sample from patient 11; this was from position 87 with an exchange of A for G. For the V3 region there was an exchange of T for A in pos 1023 in one sequence of the same sample, as well as in one sequence of patient 4 and in all the sequences of patient 7. The V1 and V3 regions of the16S rDNA in the 184 strains of Lactobacilli included in our study, thus showed extremely conserved sequences when compared with published sequences of Lactobacilli from the same niche, i.e. the human vagina. The signatures of the V1 and V3 regions also appeared remarkably consistent in each group. In addition to the previously published homologies in L. jensenii [8], we found, in some strains, base exchanges in the signatures that matched L. gasseri. No other obtained signature differed from the signature of the chosen reference strain of each group, not even when 50 nts or more were read, which was the case for most signatures. This indicates that pyrosequencing is a highly accurate and reproducible method. A recent DNA probe study from the USA [15], presents two separate types of L. crispatus which we were not able to resolve in our study. In 8 isolates of 184 we could not fulfill the stated criteria to group the isolates to one of the eleven reference-strain groups. Five gave contradictory results within the same sample, i. e. the signature of the V1 region and V3 region respectively were grouped differently. The most probable reason is that these samples contained a mix of two different species. The signatures of three other isolates were too short to fulfill the criteria for matching. These three derived from patient 17, and the remaining 12 isolates, even those selected from cultures of the same sample, were nonetheless designated as L. iners. Nine reference sequences in Table 1 represent all Lactobacilli whole genome sequences completed as of December 2007. In these strains, the number of 16S rRNA genes varies from four in L. acidophilus to nine in L. delbrüeckii (subsp. delbr.). All genes are identical in the V1 and V3 regions (for all reference strains representing these species) to the genes of the strains actually found in the study, except Lactobacillus reuteri where the sequences vary in three of the genes in the V1 region and in one in the V3 region. Based on our signature matching of the dominant Lactobacilli, the ecological niche of human vagina was monitored in a population of female partners of infertile couples, but otherwise healthy women of childbearing age. The signature-matched categorization of vaginal isolates into species-like categories led to inclusion of 182 of the 184 isolates in the overall study data (Fig. 4). When all three strains from a cultured sample were identical, only the species is indicated in each box. When two strains matched one species, and the third strain differed, the two-strain identification is denoted first (i. e. Re/G means that two of the signatures matched the sequence of L. reuteri and the third signature matched the sequence of L. gasseri). In two strains, the signatures of the V1 region and the V3 region did not match the sequences of any single reference strain.
Figure 4

Vaginal Lactobacilli and estrogen levels found in women undergoing IVF treatment.

Vaginal Lactobacilli and estrogen levels found in women undergoing IVF treatment. Earlier studies of the vaginal flora have demonstrated other species, but in some the strains were derived from culture collections where the origin either was not stated or was not properly defined [1]. However for the past decade, most studies on normal vaginal flora with PCR-based methods have demonstrated the presence and dominance of L. crispatus, L. gasseri and/or L. jensenii. These results are consistent with the result of the study at hand as well as our earlier studies of the dominant flora of women with normal vaginal flora. Some studies have not taken into account whether the bacteria found was representative of the dominating flora or not, and some reports have simply stated that the flora is considered to be normal with no further specification[1]. Moreover, several recent studies that examined the vaginal flora with DNA-probes present extensive lists of bacterial DNA clones, of which some are not possible to cultivate [16-22]. The role of Atopobium vaginae, Megasphera and other species documented in these studies, and their relation to normal flora remains unclear. In the study at hand, 10 of 17 patients continued to exhibit L. crispatus, L. gasseri and/or L. jensenii with little variation, the species dominating the flora of healthy women as shown in our previous studies (Vasquez 2002, Tärnberg 2002), cases 4–13,17. The flora of three patients was however dominated by L. delbrüeckii, L. rhamnosus or L. vaginalis. One patient had a dominance of L. iners. The remaining three had an initial flora dominated by L. rhamnosus or L. reuteri. With rising estrogen levels, the make-up of the flora altered to become dominated by one of the three species of normal vaginal flora. Thus three cases (14–16) are dominated by species that are not normally found dominating the flora of healthy women. All the samples of these women were collected within a time span of less than 20 days. This might be too short a time for a shift to the species normally found. The changes occuring in the flora of the three first patients might merely be an indicator that the flora with rising estrogen levels shifts, from being dominated with species not normally found in healthy floras, to a flora normally found in healthy women. This issue has to our knowledge never been addressed before. L. iners was frequently found in a recent study of vaginal flora [23] and in three studies [17,21,24]L. iners was found in vaginas with abnormal flora. This raises the question whether L. iners should indeed be regarded as a member of the normal flora in vaginal fluid, considered to date to be dominated by L. crispatus, L. gasseri and L. jensenii [1]. Of special interest therefore, are three of the patients who were excluded from our study. Two of the patients originally recruited were found to have a BV infection and were treated with metronidazole 2 g in single dose. One week later, each exhibited normal vaginal flora, according to Amsel's and Nugent's criteria, and IVF treatment could start. One of them returned to the clinic once and the Gram-stainable flora had not changed. The third presented initially an altered flora (dominated by Gram positive cocci) that converted with rising estrogen levels to a flora dominated by Gram-positive rods, i. e. normal vaginal flora. Since the three randomly selected colonies from the flora of these patients only grew on horse blood agar, we progressed with culture and pyrosequencing of one sample from each patient. They all matched the sequences of L. iners [25]. This is in accordance with a recent study from Ferris et al [16] and supports the findings that L. iners might be the first Lactobacillus species to establish after BV or is associated with BV as such. In studies including patients infected with BV, the most prevalent Lactobacillus species is L. iners [16,21,24]. L. iners might have a position as the species establishing primarily after BV, occupying the space of the mucous membrane lining the vagina, producing lactate and thus restoring acid pH to create a milieu favorable for the overgrowth of the normally dominant Lactobacillus species. Some support for this idea can be found in the comparison of samples of fifteen patients participating in our first two studies [6,7], (separated by a three-year interval) that show consistently dominating species in eleven women. The vaginal flora of two women changed from dominance by L. gasseri to L. crispatus and L. jensenii respectively. One instance of changed dominating flora was from L. crispatus to L. gasseri and one from L. iners to L. crispatus (unpublished data). Two recent studies of vaginal flora relate such change to corresponding hormonal changes. In the first study, the normal flora of women in early pregnancy is described, but lactobacilli not cultivable on MRS agar are excluded [26]. The other study does not distinguish among different species of lactobacilli [27]. In conclusion, signature matching of nts in the V1 and V3 regions of 16sRNA genes is a discriminative tool for the study of vaginal Lactobacilli with a possibility to reliably subtype certain species. The method can be used to follow the Lactobacillus flora under differing physiological conditions.

Authors' contributions

TJ carried out the molecular genetic studies, participated in the sequence alignment and drafted the manuscript. UF participated in the design of the study and participated in the sequence alignment. TJ and UF conceived of the study, and participated in its design and coordination. TJ and UF read and approved the final manuscript.
  25 in total

1.  Characterization of vaginal microflora of healthy, nonpregnant women by chaperonin-60 sequence-based methods.

Authors:  Janet E Hill; Swee Han Goh; Deborah M Money; Melissa Doyle; Andra Li; William L Crosby; Matthew Links; Amy Leung; Debbie Chan; Sean M Hemmingsen
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

2.  Vaginal lactobacilli, probiotics, and IVF.

Authors:  Hans Verstraelen; Abiola C Senok
Journal:  Reprod Biomed Online       Date:  2005-12       Impact factor: 3.828

3.  Cultivation-independent analysis of changes in bacterial vaginosis flora following metronidazole treatment.

Authors:  Michael J Ferris; Johana Norori; Marcela Zozaya-Hinchliffe; David H Martin
Journal:  J Clin Microbiol       Date:  2007-01-03       Impact factor: 5.948

4.  Bacterial vaginal flora in relation to changing oestrogen levels.

Authors:  J D Wilson; R A Lee; A H Balen; A J Rutherford
Journal:  Int J STD AIDS       Date:  2007-05       Impact factor: 1.359

5.  Lactobacillus iners: a marker of changes in the vaginal flora?

Authors:  Tell Jakobsson; Urban Forsum
Journal:  J Clin Microbiol       Date:  2007-07-25       Impact factor: 5.948

6.  Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis.

Authors:  David N Fredricks; Tina L Fiedler; Katherine K Thomas; Brian B Oakley; Jeanne M Marrazzo
Journal:  J Clin Microbiol       Date:  2007-08-08       Impact factor: 5.948

Review 7.  Bacterial vaginosis--a microbiological and immunological enigma.

Authors:  U Forsum; E Holst; P G Larsson; A Vasquez; T Jakobsson; I Mattsby-Baltzer
Journal:  APMIS       Date:  2005-02       Impact factor: 3.205

8.  Lactobacillus vaginal microbiota of women attending a reproductive health care service in Benin city, Nigeria.

Authors:  Kingsley C Anukam; Emmanuel O Osazuwa; Ijeoma Ahonkhai; Gregor Reid
Journal:  Sex Transm Dis       Date:  2006-01       Impact factor: 2.830

9.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

10.  Microbes on the human vaginal epithelium.

Authors:  Richard W Hyman; Marilyn Fukushima; Lisa Diamond; Jochen Kumm; Linda C Giudice; Ronald W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

View more
  8 in total

Review 1.  Potential influence of the microbiome on infertility and assisted reproductive technology.

Authors:  Ido Sirota; Shvetha M Zarek; James H Segars
Journal:  Semin Reprod Med       Date:  2014-01-03       Impact factor: 1.303

2.  The dynamics of the vaginal microbiome during infertility therapy with in vitro fertilization-embryo transfer.

Authors:  Richard W Hyman; Christopher N Herndon; Hui Jiang; Curtis Palm; Marilyn Fukushima; Denise Bernstein; Kim Chi Vo; Zara Zelenko; Ronald W Davis; Linda C Giudice
Journal:  J Assist Reprod Genet       Date:  2012-01-06       Impact factor: 3.412

Review 3.  The vaginal microbiota: what have we learned after a decade of molecular characterization?

Authors:  Janneke H H M van de Wijgert; Hanneke Borgdorff; Rita Verhelst; Tania Crucitti; Suzanna Francis; Hans Verstraelen; Vicky Jespers
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

4.  Association of vaginal bacterial communities and reproductive outcomes with prophylactic antibiotic exposure in a subfertile population undergoing in vitro fertilization: a prospective exploratory study.

Authors:  Ashley M Eskew; Molly J Stout; Bronwyn S Bedrick; Joan K Riley; Brandi N Herter; Haley Gula; Emily S Jungheim; Kristine M Wylie
Journal:  F S Sci       Date:  2021-01-11

5.  Variability of the response of human vaginal Lactobacillus crispatus to 17β-estradiol.

Authors:  Maximilien Clabaut; Amine M Boukerb; Amine Ben Mlouka; Amandine Suet; Ali Tahrioui; Julien Verdon; Magalie Barreau; Olivier Maillot; Agathe Le Tirant; Madina Karsybayeva; Coralie Kremser; Gérard Redziniak; Cécile Duclairoir-Poc; Chantal Pichon; Julie Hardouin; Pascal Cosette; Sylvie Chevalier; Marc G J Feuilloley
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

6.  Microorganisms within human follicular fluid: effects on IVF.

Authors:  Elise S Pelzer; John A Allan; Mary A Waterhouse; Tara Ross; Kenneth W Beagley; Christine L Knox
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

7.  Hormone-dependent bacterial growth, persistence and biofilm formation--a pilot study investigating human follicular fluid collected during IVF cycles.

Authors:  Elise S Pelzer; John A Allan; Christina Theodoropoulos; Tara Ross; Kenneth W Beagley; Christine L Knox
Journal:  PLoS One       Date:  2012-12-04       Impact factor: 3.240

Review 8.  Role of Lactobacilli and Lactoferrin in the Mucosal Cervicovaginal Defense.

Authors:  Piera Valenti; Luigi Rosa; Daniela Capobianco; Maria Stefania Lepanto; Elisa Schiavi; Antimo Cutone; Rosalba Paesano; Paola Mastromarino
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.